Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,248,417
+$765,938 QoQ
Shares Held
31,032
+61.6% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Odyssean, LLC holds $19,530,852 across 24 Biotechnology names. APLS ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
32,778 | $1,572,360 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
9,273 | $1,567,322 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,957 | $1,512,056 | |
| 4 | RARE |
Ultragenyx Pharmaceutical Inc.
|
67,412 | $1,412,281 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
This page
|
31,032 | $1,248,417 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
4,819 | $1,244,844 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
14,821 | $1,234,441 | |
| 8 | PCVX |
Vaxcyte, Inc.
|
20,111 | $1,168,650 |
All Filings in APLS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,248,417 | 31,032 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $482,479 | 19,207 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||